Luca Mologni

Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification

Philipp le Coutre, Marileila Varella‐Garcia, Rossella Barni et al. · Blood · 2000 · 487 citations

Medicine, Molecular Biology, Pharmacology +15

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

Rocco Piazza, Simona Valletta, Nils Winkelmann et al. · Nature Genetics · 2012 · 425 citations · Full text

Medicine, Genetics, Oncology +11

In Vivo Eradication of Human BCR/ABL-Positive Leukemia Cells With an ABL Kinase Inhibitor

Philipp le Coutre, Luca Mologni, Loredana Cleris et al. · JNCI Journal of the National Cancer Institute · 1999 · 378 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of the ABL Kinase Activity Blocks the Proliferation of BCR/ABL+Leukemic Cells and Induces Apoptosis

Carlo Gambacorti‐Passerini, Philipp le Coutre, Luca Mologni et al. · Blood Cells Molecules and Diseases · 1997 · 319 citations

Life Sciences, Cancer Biology, Oncology +12

Entrectinib, a Pan–TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications

Elena Ardini, Maria Menichincheri, Patrizia Banfi et al. · Molecular Cancer Therapeutics · 2016 · 312 citations · Full text

Medicine, Oncology, Pharmacology +17